Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.35 |
| ▸ | CA4 | P22748 | 4/20 | 0.35 |
| ▸ | CA9 | Q16790 | 4/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | GLP1R | P43220 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | GHSR | Q92847 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23797092 | 0.91 | GLP1R (0.31) | MEN1KMT2ACA12CA1CA2 | |
| SCHEMBL3538740 | 0.87 | MEN1 (0.39) | MEN1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL15424356 | 0.80 | SLC1A2 (0.43) | KMT2A | |
| SCHEMBL16309272 | 0.80 | SLC1A2 (0.43) | KMT2A | |
| SCHEMBL26005443 | 0.80 | MEN1 (0.37) | MEN1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL3529941 | 0.78 | TSHR (0.37) | ALDH1A1TSHR | |
| SCHEMBL4270081 | 0.78 | TSHR (0.46) | MEN1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL16349899 | 0.78 | ALDH1A1 (0.47) | MEN1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL19431099 | 0.76 | MEN1 (0.47) | MEN1KMT2AALDH1A1CA12CA1 | |
| SCHEMBL26740079 | 0.76 | GLP1R (0.34) | MEN1KMT2AALDH1A1GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021195307-A1 | CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF | ALNYLAM PHARMACEUTICALS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |